Innovis Asset Management »

Autolus Therapeutics Plc spon ads shares owned by Innovis Asset Management

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Innovis Asset Management from 13F filings

Historical chart of Innovis Asset Management investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Innovis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Innovis Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $147k 63k 2.33
2023-06-30 $150k 63k 2.38
2023-03-31 $232k 126k 1.84

More positions owned by Innovis Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Hess (HES)
CBOE Holdings (CBOE)
Vertex Pharmaceuticals Incorporated (VRTX)
Costco Wholesale Corporation (COST)
Merck & Co (MRK)
Microsoft Corporation (MSFT)
Intuitive Surgical Com New (ISRG)
Alphabet Cap Stk Cl A (GOOGL)
Boston Scientific Corporation (BSX)
Newmont Mining Corporation (NEM)
Amazon (AMZN)
Emerson Electric (EMR)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Innovis Asset Management

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
FMR
Polygon Management
Cormorant Asset Management
Paradigm Biocapital Advisors
T. Rowe Price Associates
Armistice Capital
Frazier Life Sciences Management
Perceptive Advisors
BlackRock
Deerfield Management Company
Adage Capital Partners GP
Commodore Capital
Perpetual

View all funds holding Autolus Therapeutics Plc spon ads